Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genomic Vision is a biotechnology company focused on developing and commercializing tools and services for genetic analysis based on its proprietary Molecular Combing technology. This innovative platform enables direct visualization and analysis of single DNA molecules, allowing for precise detection of large-scale genomic variations, DNA replication analysis, and genome stability assessment. Genomic Vision's solutions cater to life sciences research, drug discovery and development, and diagnostics, particularly in areas like cancer, genetic diseases, and gene therapy. The company aims to provide high-resolution genomic insights to advance personalized medicine and biopharmaceutical research.
The headquarters serves as the primary center for research and development of Molecular Combing technology, corporate administration, strategic planning, and global operational management.
The facility likely includes state-of-the-art laboratories equipped for molecular biology, genomics research, and the specialized requirements of Molecular Combing technology, fostering an environment of scientific innovation.
Characterized by a highly scientific, innovative, and collaborative atmosphere, with a strong emphasis on precision, research excellence, and translating genomic discoveries into practical applications.
As the birthplace and core development site of Genomic Vision's proprietary technology, the headquarters is crucial for maintaining its scientific leadership, protecting intellectual property, and driving the company's growth strategy in the global genomics market.
Genomic Vision operates globally from its French headquarters, extending its reach through a robust network of specialized distribution partners in key international markets. This network ensures that its Molecular Combing technology, diagnostic tests, and research services are available to academic institutions, pharmaceutical companies, and clinical laboratories across North America, Europe, and Asia, supporting diverse applications in genomics.
Bâtiment La Serre, 80-84 Rue des Meuniers
Bagneux
Île-de-France
France
Address: Not a direct company office; services provided through local/regional distribution partners.
To ensure accessibility of Genomic Vision's advanced genomic analysis tools to researchers, clinicians, and pharmaceutical companies worldwide, tailoring support to local market needs and regulations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genomic Vision' leadership includes:
Genomic Vision has been backed by several prominent investors over the years, including:
Genomic Vision has undergone significant leadership renewal over the past 12-18 months, including the appointment of a new CEO, Dominique Remy-Renou, in January 2024, and a new CFO, Mohamed Ihmaichen, in March 2023. These changes follow the transition of co-founder Aaron Bensimon from his executive role in early 2023.
Discover the tools Genomic Vision uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Genomic Vision's exact email format policy isn't publicly detailed, a common structure for companies of its type and region is [first_initial].[last_name]@genomicvision.com. Variations may exist for different departments or roles.
[first_initial].[last_name]@genomicvision.com
Format
d.remy-renou@genomicvision.com
Example
75%
Success rate
Genomic Vision Press Release • March 6, 2024
Genomic Vision announced the drawdown of a new tranche of €0.5 million under its existing EHGOCAB (Equity Hybrid Line with Winance) financing agreement. This funding is intended to support its working capital requirements and ongoing development programs....more
Genomic Vision Press Release • January 8, 2024
Genomic Vision announced the appointment of Dominique Remy-Renou as its new Chief Executive Officer and member of the Management Board, effective January 15, 2024. Her extensive experience in the life sciences industry is expected to drive the company's strategic growth and commercialization efforts....more
Genomic Vision Press Release • October 19, 2023
Genomic Vision released its financial results for the first half of 2023, highlighting revenue streams, R&D progress, and operational updates. The company emphasized ongoing efforts in developing its diagnostic tests and research applications for its Molecular Combing technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genomic Vision, are just a search away.